Xinbang Pharmaceutical has three subsidiaries, namely, Guizhou Xinbang Far East Pharmaceutical Co., Ltd., Guizhou Xinbang Pharmaceutical Co., Ltd. and Guizhou Xinbang Pharmaceutical R&D Co., Ltd., and has built Kaili Chinese herbal medicine planting and extraction production base, Luodian solid preparation production base and Guiyang injection production base.
Xinbang Pharmaceutical's main business is the research, development, production and sales of proprietary Chinese medicines, and its products are mainly cardiovascular and cerebrovascular diseases and digestive system diseases. At present, there are 46 ethnic medicines with quasi-famous brands, including 4 national high-quality and high-priced varieties, 4 protected varieties of traditional Chinese medicine and 2 exclusive varieties.
The company has applied for 47 patents (including 38 invention patents, 8 design patents and utility model 1 item), and the company's "Bangxiao 'an" and "Xinbang" trademarks were rated as "famous trademarks in Guizhou Province".
In terms of marketing system construction, the company has carefully built its own marketing system and team, and set up 70 offices in 29 provinces, municipalities and autonomous regions.
In the future development, Xinbang Pharmaceutical will, as always, build and maintain the brand image of "Xinbang" with high-quality and efficient products, thoughtful and meticulous after-sales service and good reputation, and create greater wealth for the society and benefit patients and mulberry.